CONFERENCE COVERAGE
American Society of Hematology Annual Meeting
- Venetoclax and Ibrutinib: A New Standard for Relapsed/Refractory MCL?
- Wearable Device Detects CRS in CAR-T Therapy Earlier Than Standard-of-Care Nurse Monitoring
- Ivosidenib vs Venetoclax: A Comparison of Efficacy, Safety of Regimens for mIDH1 AML
- SDOH Drive Disparities in Access to Cancer Care Among Undeserved Populations
- Financial Toxicity High With Myeloma, Navigation May Help Find Aid, Solutions
- Benefits of Iron Chelation Therapy Unveiled in Analysis of Low-Risk MDS
- Palliative Care During In-Patient HSCT Improves Quality of Life, Reduces Depression
- Olverembatinib Improves EFS in TKI-Resistant Chronic Phase CML
- B-Cell Depletion With Obinutuzumab May Prevent GVHD
- Neurocognitive Outcomes Dip at 1 Month Post-CAR-T Therapy but Rebound by Month 3
- Clinical Frailty Scores Predict Survival After CAR-T Therapy for B-Cell Lymphoma
- Sequence of Second-Line to Third-Line Therapy in RR TNKL Has No Effect on Outcomes
Conference Coverage from
